Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea
· Delayed Price · Currency is KRW 1,019,000
-10,000 (-0.97%)
At close: Jun 13, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
| Contract Development and Manufacturing Organization (CDMO) | 3,009.62B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Development and Manufacturing Organization (CDMO) Growth | 12.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceutical Development and Commercialization | 1,537.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceutical Development and Commercialization Growth | 50.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product | 4,165.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | 22.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 382.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 31.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
| Contract Development and Manufacturing Organization (CDMO) Operating Profit | 1,119.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Development and Manufacturing Organization (CDMO) Operating Profit Growth | 2.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceutical Development and Commercialization Operating Profit | 200.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceutical Development and Commercialization Operating Profit Growth | 688.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
| Domestic | 135.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Domestic Growth | 17.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 2,963.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 25.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| USA | 1,174.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| USA Growth | 20.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic | 274.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Growth | 7.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|